This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
6zsr
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Crystal structure of the Cisplatin beta-Lactoglobulin adduct formed after 72 h of soaking== | ==Crystal structure of the Cisplatin beta-Lactoglobulin adduct formed after 72 h of soaking== | ||
| - | <StructureSection load='6zsr' size='340' side='right'caption='[[6zsr]]' scene=''> | + | <StructureSection load='6zsr' size='340' side='right'caption='[[6zsr]], [[Resolution|resolution]] 2.00Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6ZSR OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[6zsr]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Bos_taurus Bos taurus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6ZSR OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6ZSR FirstGlance]. <br> |
| - | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.005Å</td></tr> |
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NH3:AMMONIA'>NH3</scene>, <scene name='pdbligand=PT:PLATINUM+(II)+ION'>PT</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6zsr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6zsr OCA], [https://pdbe.org/6zsr PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6zsr RCSB], [https://www.ebi.ac.uk/pdbsum/6zsr PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6zsr ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/LACB_BOVIN LACB_BOVIN] Primary component of whey, it binds retinol and is probably involved in the transport of that molecule. | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | beta-Lactoglobulin is a major globular milk whey carrier with potential applications as an oral drug delivery system. Herein, the interactions between beta-lactoglobulin and cisplatin are investigated by UV-Vis absorption spectroscopy, circular dichroism, X-ray crystallography and electrospray ionization mass spectrometry. Structural data indicate that the protein retains its conformation upon cisplatin binding. Pt-containing fragments bind the side chains of Met7, His146 and Lys8, with the number of binding sites increasing over time. Mass spectrometry data indicate that [Pt(NH3)2Cl+], [Pt(NH3)2OH22+] and [Pt(NH3)22+] fragments interact with beta-lactoglobulin; up to 3 cisplatin fragments can bind the protein and the number of cisplatin binding sites increases over time. This work opens a new pathway in pharmaceutical studies based on a rational design of metal-based drug/beta-lactoglobulin adducts as delivering vehicles of metallodrugs. | ||
| + | |||
| + | Cisplatin binding to beta-lactoglobulin: a structural study.,Balasco N, Ferraro G, Loreto D, Iacobucci I, Monti M, Merlino A Dalton Trans. 2020 Sep 15;49(35):12450-12457. doi: 10.1039/d0dt02582h. PMID:32852026<ref>PMID:32852026</ref> | ||
| + | |||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
| + | <div class="pdbe-citations 6zsr" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Beta-lactoglobulin 3D structures|Beta-lactoglobulin 3D structures]] | ||
| + | == References == | ||
| + | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Bos taurus]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Balasco N]] | [[Category: Balasco N]] | ||
[[Category: Ferraro G]] | [[Category: Ferraro G]] | ||
[[Category: Merlino A]] | [[Category: Merlino A]] | ||
Current revision
Crystal structure of the Cisplatin beta-Lactoglobulin adduct formed after 72 h of soaking
| |||||||||||
